belotero balance

a highly cross-linked hyaluronic acid used as a dermal filler

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Bierman, Dina: 1 article (10/2017)
2.	Gandy, Jessica: 1 article (10/2017)
3.	Zachary, Christopher: 1 article (10/2017)
4.	Howell, David J: 1 article (05/2015)
5.	Moradi, Amir: 1 article (05/2015)
6.	Moradi-Poehler, Jeanette: 1 article (05/2015)
7.	Shirazi, Azadeh: 1 article (05/2015)
8.	Turner, Jessica: 1 article (05/2015)
9.	Fagien, Steven: 1 article (10/2013)
10.	Flynn, Timothy C: 1 article (10/2013)

1.	Pain (Aches) 05/01/2015 - "The investigators explored the severity of bruising and pain in patients treated with the cohesive polydensified matrix HA (CPMHA) in 3 different preparations: CPMHA (Belotero Balance [BEL]), CPMHA with lidocaine (BEL-L), and CPMHA with lidocaine and epinephrine (BEL-LE). "
2.	Granuloma 10/01/2013 - "Finally, a 5-year retrospective safety review of 317 patients treated with Belotero Balance over a 5-year period revealed no severe adverse events in any patients, including the absence of persistent nodules or granulomas."
3.	Foreign-Body Reaction 10/01/2017 - "We present the first case of a patient who developed a severe granulomatous foreign body reaction to the HA filler, Belotero Balance. "